What is the Aarti Pharmalabs Ltd share price today?

The share price of NSE:AARTIPHARM-EQ on 01 Oct 2026 (as of 15:02:55 IST) is ₹947.45.

What is the NSE:AARTIPHARM-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:AARTIPHARM-EQ 52 week high low range shows a high of ₹1002.4 and a low of ₹585.

What is the Aarti Pharmalabs Ltd market cap?

As on 01 Oct 2026, Aarti Pharmalabs Ltd market cap is ₹86349800000.

What is the shareholding pattern of Aarti Pharmalabs Ltd Stock?

The shareholding pattern of Aarti Pharmalabs Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 42.86% Foreign Institutional Investors (FII): 8.17% Domestic Institutional Investors (DII): 6.42% Mutual Funds: 0.79% Retail & Others: 41.76% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Aarti Pharmalabs Ltd?

The Price-to-Earnings (PE) ratio of Aarti Pharmalabs Ltd is 40.5121, and the Price-to-Book (PB) ratio is 2.518, as on 01 Oct 2026.

Aarti Pharmalabs Share Price

919.95+0.00 (+3.50%)

+7.22% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+3.50%

1 Week

+5.41%

1 Month

-2.82%

3 Month

+32.89%

6 Month

+20.07%

YTD

+22.27%

1 Year

+7.22%

5 Year

NA

10 Year

NA

Max

+206.75%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

895.00

870.05

782.00

683.00

604.15

585.00

High

931.20

987.00

1002.40

About

Aarti Pharmalabs Limited (APL) (Formerly known as Aarti Organics Limited) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint. The company is an, internationally recognised manufacturer Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

AARTIPHARMNSE

LTP

1W Low

1W High

Market cap (₹)

1769.9-7.8 (-0.44%)

1722

1855

4,24,202Cr

10064+284 (2.90%)

9621.50

10064

2,64,141Cr

4650+36.6 (0.79%)

4532

4675

1,74,402Cr

2323-82.5 (-3.43%)

2206.10

2441.90

1,26,811Cr

1240.6-4.9 (-0.39%)

1182

1254.20

1,23,685Cr

1368.3+16.3 (1.21%)

1336.70

1368.30

1,11,868Cr

1396.9+18 (1.31%)

1357

1396.90

1,11,650Cr

2475-17.8 (-0.71%)

2457.90

2528

1,02,196Cr

1694.5+13.1 (0.78%)

1647.20

1697.40

96,951Cr

2015.9+4.9 (0.24%)

1974

2033.80

91,301Cr

919.95+47.25 (5.41%)

865

938

8,070Cr

Aarti Pharmalabs Share Price

919.95+0.00 (+3.50%)

+7.22% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-2%

Last year-14%

Compounded Profit Growth

10 years-

5 years-

3 years-3%

Last year-36%

Stock Price CAGR

10 years-

5 years-

3 years33%

1 year7%

Return on Equity

10 years11%

5 years14%

3 years12%

Last year9%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-2%	-14%
-	-	-3%	-36%
-	-	33%	7%
11%	14%	12%	9%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

AARTIPHARM

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
919.95	₹8070 Cr	31.44	7.88	41.25	₹175 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
₹610 Cr	₹536 Cr	₹583 Cr	₹432 Cr	₹418 Cr	₹386 Cr	₹564 Cr	₹538 Cr	₹458 Cr	₹555 Cr	₹506 Cr	₹449 Cr	₹440 Cr	₹458 Cr	₹485 Cr	₹472 Cr	₹531 Cr	₹457 Cr	₹460 Cr
₹47 L	₹45 L	₹8 Cr	-₹37 L	₹48 L	₹77 L	₹86 L	₹5 Cr	₹4 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹99 L	₹48 L	₹74 L	₹29 L	₹1 Cr	₹2 L	₹3 Cr
₹611 Cr	₹536 Cr	₹591 Cr	₹432 Cr	₹419 Cr	₹387 Cr	₹565 Cr	₹543 Cr	₹463 Cr	₹558 Cr	₹508 Cr	₹450 Cr	₹441 Cr	₹459 Cr	₹486 Cr	₹472 Cr	₹532 Cr	₹457 Cr	₹463 Cr
₹506 Cr	₹430 Cr	₹498 Cr	₹359 Cr	₹379 Cr	₹318 Cr	₹443 Cr	₹432 Cr	₹385 Cr	₹479 Cr	₹407 Cr	₹372 Cr	₹370 Cr	₹391 Cr	₹421 Cr	₹402 Cr	₹458 Cr	₹385 Cr	₹399 Cr
₹136 Cr	₹137 Cr	₹121 Cr	₹102 Cr	₹65 Cr	₹92 Cr	₹144 Cr	₹134 Cr	₹98 Cr	₹99 Cr	₹120 Cr	₹97 Cr	₹89 Cr	₹85 Cr	₹81 Cr	₹87 Cr	₹91 Cr	₹86 Cr	₹78 Cr
₹15 Cr	₹13 Cr	₹17 Cr	₹13 Cr	₹11 Cr	₹7 Cr	₹7 Cr	₹10 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹4 Cr	₹5 Cr
₹88 Cr	₹94 Cr	₹76 Cr	₹58 Cr	₹29 Cr	₹63 Cr	₹115 Cr	₹101 Cr	₹72 Cr	₹74 Cr	₹96 Cr	₹74 Cr	₹67 Cr	₹64 Cr	₹59 Cr	₹65 Cr	₹69 Cr	₹68 Cr	₹59 Cr
₹65 Cr	₹69 Cr	₹56 Cr	₹43 Cr	₹21 Cr	₹48 Cr	₹88 Cr	₹74 Cr	₹55 Cr	₹55 Cr	₹65 Cr	₹53 Cr	₹52 Cr	₹47 Cr	₹43 Cr	₹48 Cr	₹51 Cr	₹52 Cr	₹49 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
—	—	—	—	—	—
₹45 Cr	₹45 Cr	₹45 Cr	₹45 Cr	₹25 L	₹25 L
₹3 Cr	₹2 Cr	₹23 L	₹0	₹45 Cr	₹0
₹2076 Cr	₹1943 Cr	₹1712 Cr	₹1513 Cr	₹1341 Cr	-₹2 L
₹2076 Cr	₹1943 Cr	₹1712 Cr	₹1513 Cr	₹1341 Cr	-₹2 L
₹2125 Cr	₹1990 Cr	₹1757 Cr	₹1558 Cr	₹1386 Cr	₹23 L
₹186 Cr	₹104 Cr	₹4 L	₹18 L	₹55 L	₹0
₹134 Cr	₹128 Cr	₹108 Cr	₹79 Cr	₹71 Cr	₹0
₹92 Cr	₹19 Cr	₹17 Cr	₹53 L	₹2 Cr	₹0
₹8 Cr	₹8 Cr	₹6 Cr	₹5 Cr	₹0	₹0
₹420 Cr	₹259 Cr	₹131 Cr	₹85 Cr	₹73 Cr	₹0
—	—	—	—	—	—
₹335 Cr	₹278 Cr	₹378 Cr	₹340 Cr	₹215 Cr	₹26,000
₹135 Cr	₹70 Cr	₹46 Cr	₹38 Cr	₹12 Cr	₹20,000
₹457 Cr	₹293 Cr	₹264 Cr	₹214 Cr	₹338 Cr	₹2 L
₹11 Cr	₹13 Cr	₹6 Cr	₹9 Cr	₹16 Cr	₹0
₹938 Cr	₹653 Cr	₹694 Cr	₹601 Cr	₹581 Cr	₹2 L
₹3482 Cr	₹2902 Cr	₹2582 Cr	₹2244 Cr	₹2040 Cr	₹25 L
₹8 Cr	₹14 Cr	₹7 Cr	₹7 Cr	₹0	₹0
₹686 Cr	₹396 Cr	₹264 Cr	₹214 Cr	₹339 Cr	₹2 L
—	—	—	—	—	—
₹2135 Cr	₹1796 Cr	₹1609 Cr	₹1431 Cr	₹1225 Cr	₹0
₹697 Cr	₹659 Cr	₹576 Cr	₹505 Cr	₹443 Cr	₹0
₹1437 Cr	₹1137 Cr	₹1033 Cr	₹926 Cr	₹782 Cr	₹0
₹305 Cr	₹307 Cr	₹78 Cr	₹62 Cr	₹165 Cr	₹0
₹194 Cr	₹29 Cr	₹37 Cr	₹36 Cr	₹32 Cr	₹0
₹194 Cr	₹29 Cr	₹37 Cr	₹36 Cr	₹32 Cr	₹0
₹60 Cr	₹44 Cr	₹29 Cr	₹18 Cr	₹10 Cr	₹0
₹2084 Cr	₹1584 Cr	₹1236 Cr	₹1081 Cr	₹1012 Cr	₹0
—	—	—	—	—	—
₹0	₹48 Cr	₹70 Cr	₹51 Cr	₹0	₹0
₹640 Cr	₹588 Cr	₹643 Cr	₹602 Cr	₹475 Cr	₹0
₹583 Cr	₹575 Cr	₹519 Cr	₹450 Cr	₹377 Cr	₹0
₹10 Cr	₹9 Cr	₹24 Cr	₹12 Cr	₹83 Cr	₹25 L
₹12 Cr	₹12 Cr	₹17 Cr	₹8 Cr	₹11 Cr	₹0
₹152 Cr	₹87 Cr	₹72 Cr	₹40 Cr	₹82 Cr	₹0
₹1397 Cr	₹1318 Cr	₹1346 Cr	₹1163 Cr	₹1028 Cr	₹25 L
₹460 Cr	₹665 Cr	₹651 Cr	₹562 Cr	₹447 Cr	₹23 L
₹3482 Cr	₹2902 Cr	₹2582 Cr	₹2244 Cr	₹2040 Cr	₹25 L
₹234	₹219	₹194	₹172	₹53,647	₹9
₹234	₹219	₹194	₹172	₹53,647	₹9

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
₹228 Cr	₹361 Cr	₹300 Cr	₹261 Cr	₹155 Cr	-₹46,000
₹188 Cr	₹120 Cr	₹95 Cr	₹83 Cr	₹52 Cr	₹0
-₹107 Cr	-₹86 Cr	-₹122 Cr	-₹32 Cr	-₹230 Cr	₹46,000
₹309 Cr	₹395 Cr	₹273 Cr	₹312 Cr	-₹23 Cr	₹0
₹262 Cr	₹330 Cr	₹216 Cr	₹250 Cr	-₹44 Cr	₹0
-₹431 Cr	-₹412 Cr	-₹215 Cr	-₹158 Cr	-₹139 Cr	₹0
₹171 Cr	₹65 Cr	₹10 Cr	-₹163 Cr	₹260 Cr	₹0
₹2 Cr	-₹17 Cr	₹12 Cr	-₹71 Cr	₹78 Cr	₹0
₹7 Cr	₹24 Cr	₹12 Cr	₹83 Cr	₹5 Cr	₹25 L
₹9 Cr	₹7 Cr	₹24 Cr	₹12 Cr	₹83 Cr	₹25 L

Fundamental Ratios

Consolidated

Standalone

No results found

Aarti Pharmalabs Share Price

919.95+0.00 (+3.50%)

+7.22% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Aarti Pharmalabs Share Price

919.95+0.00 (+3.50%)

+7.22% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 5

Bearish signals: 1 out of 9 oscillators

RSI

56.60Buy

STOCH %K

73.38Neutral

MACD Level(12,26)

4.31Buy

Ultimate Oscillator

54.63Buy

Aroon Oscillator

20.00Sell

BOP

0.61Buy

CCI

81.66Neutral

Williams %R

-26.62Neutral

Momentum

35.45Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 9

Bearish signals: 0 out of 9 moving averages

EMA 9

885.25Buy

SMA 9

872.19Buy

EMA 21

879.89Buy

SMA 21

881.08Buy

EMA 50

859.51Buy

SMA 50

872.16Buy

EMA 200

789.52Buy

SMA 200

749.35Buy

WMA 20

873.29Buy

Pivot

Classic

Resistance 5

999.80

Resistance 4

971.30

Resistance 3

942.80

Resistance 2

914.30

Resistance 1

901.55

Pivot

885.80

Support 1

873.05

Support 2

857.30

Support 3

828.80

Support 4

800.30

Support 5

771.80

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

895.00

870.05

782.00

683.00

604.15

585.00

380.05

234.80

High

931.20

987.00

1002.40

Returns

+0.00

+47.25

-26.65

+227.70

+153.75

+167.55

+61.95

+528.45

—

+620.05

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

Aarti Pharmalabs Share Price

919.95+0.00 (+3.50%)

+7.22% past 1 Year

Shareholding summary

Promoters

39.66%

FII

8.16%

DII

7.8%

MF

0.6%

Others

43.78%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
39.66%	42.86%	43.08%	43.10%	42.88%	43.72%
8.16%	8.17%	8.39%	7.68%	8.02%	7.34%
7.80%	6.42%	6.60%	6.57%	6.16%	6.90%
0.60%	0.79%	0.80%	1.09%	0.79%	0.90%
43.78%	41.76%	41.13%	41.56%	42.15%	41.14%

Bulk & block deals

Name

Unifi Capital Private Limited

Jasmine Family Trust

Nk Securities Research Private Limited

Microcurves Trading Private Limited

Junomoneta Finsol Private Limited

Nk Securities Research Private Limited

Qe Securities Llp

Microcurves Trading Private Limited

Qe Securities Llp

Junomoneta Finsol Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
21 Sep 2026	Purchase	75.03 Cr	₹820	9.15 L	Bulk	1.009045	NSE
18 Sep 2026	Sell	51.46 Cr	₹820.02	6.28 L	Bulk	0.691995	NSE
11 Aug 2026	Sell	57.90 Cr	₹903.73	6.41 L	Bulk	0.7065	NSE
11 Aug 2026	Sell	64.84 Cr	₹904.35	7.17 L	Bulk	0.790725	NSE
11 Aug 2026	Sell	41.10 Cr	₹902.03	4.56 L	Bulk	0.502494	NSE
11 Aug 2026	Purchase	57.85 Cr	₹903.39	6.40 L	Bulk	0.706239	NSE
11 Aug 2026	Sell	51.43 Cr	₹902.18	5.70 L	Bulk	0.628595	NSE
11 Aug 2026	Purchase	64.82 Cr	₹903.94	7.17 L	Bulk	0.790725	NSE
11 Aug 2026	Purchase	51.88 Cr	₹899.52	5.77 L	Bulk	0.636026	NSE
11 Aug 2026	Purchase	41.29 Cr	₹901.69	4.58 L	Bulk	0.505008	NSE

Insider trading & SAST

Client name

Gloire Trusteeship Services Private Limited

Rajendra Vallabhaji Gogri

Arti Rajendra Gogri

Relacion Trusteeship Services Private Limited

Gloire Trusteeship Services Private Limited

Safechem Enterprises Private Limited

Relacion Trusteeship Services Private Limited

Safechem Enterprises Private Limited

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
25 Sep 2026	Promoter Group	Disposal	0.438356	0	32.55 Cr	₹818.77	3.98 L	21 Sep 2026 - 22 Sep 2026	Market Sale	0	Insider Trading	—	Equity
25 Sep 2026	Promoter	Disposal	0.428679	1.14	31.83 Cr	₹818.77	3.89 L	21 Sep 2026 - 22 Sep 2026	Market Sale	10,37,175	Insider Trading	—	Equity
25 Sep 2026	Promoter Group	Disposal	0.147292	0.35	10.94 Cr	₹818.77	1.34 L	21 Sep 2026 - 22 Sep 2026	Market Sale	3,21,692	Insider Trading	—	Equity
25 Sep 2026	Promoter	Disposal	0.419057	0	31.12 Cr	₹818.83	3.80 L	21 Sep 2026 - 22 Sep 2026	Market Sale	0	Insider Trading	—	Equity
22 Sep 2026	Promoter Group	Disposal	0.691995	0	51.38 Cr	₹818.79	6.28 L	18 Sep 2026 - 19 Sep 2026	Market Sale	0	Insider Trading	—	Equity
22 Sep 2026	Promoter Group	Disposal	0.688687	0	51.14 Cr	₹818.83	6.25 L	18 Sep 2026 - 19 Sep 2026	Market Sale	0	Insider Trading	—	Equity
09 Sep 2026	Promoter Group	Disposal	0.065505	0.4	5.20 Cr	₹875.17	59.40 K	07 Sep 2026 - 08 Sep 2026	Market Sale	3,65,750	Insider Trading	—	Equity
09 Sep 2026	Promoter Group	Disposal	0.066167	0.69	5.23 Cr	₹871.08	60 K	08 Sep 2026 - 09 Sep 2026	Market Sale	6,27,500	Insider Trading	—	Equity
07 Sep 2026	Promoter Group	Disposal	0.033083	0.47	2.59 Cr	₹864.43	30 K	04 Sep 2026 - 07 Sep 2026	Market Sale	4,25,150	Insider Trading	—	Equity
31 Aug 2026	Promoter Group	Disposal	0.000662	0.5	5.12 L	₹853.15	600	26 Aug 2026 - 27 Aug 2026	Market Sale	4,55,150	Insider Trading	—	Equity

Aarti Pharmalabs Share Price

919.95+0.00 (+3.50%)

+7.22% past 1 Year

Aarti Pharmalabs Limited (APL) (Formerly known as Aarti Organics Limited) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint. The company is an, internationally recognised manufacturer

Corporate Actions

Date

Type

Details

2026-09-15

Dividend

2.0

2026-02-16

Dividend

1.5

2025-09-15

Dividend

2.5

2025-02-14

Dividend

2.5

2024-07-31

Dividend

1.0

2024-02-16

Dividend

2.0

2023-01-17

Dividend

2.0

Company details

Registered office

Plot No. 22/ C/1 & 22/ C/2 1st Phase, G. I. D. C. Valsad Vapi Gujarat PIN: 396195 Tel No: 0260 2400467 / 09909994655 Fax No: NULL Email: [email protected] Internet: www.aartipharmalabs.com

Registrars

C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/

Management

Jeevan Mondkar, Company Secretary & Compliance Officer, Legal Head

Hetal Gogri Gala, Whole Time Director

Narendra J Salvi, Managing Director

Parimal H Desai, Non Independent & Non Executive Director

Nehal Garewal, Non Independent & Non Executive Director

Bhavesh R Vora, Non Executive Independent Director

Vinay G Nayak, Non Executive Independent Director

Vilas G Gaikar, Non Executive Independent Director

Jeenal Savla, Non Executive Independent Director

Rupal Vora, Non Executive Independent Director

Pradeep Thakur, Non Executive Independent Director